Publications by authors named "Abraham Anderson"

Claim this Profile
M
Molecular determinants of sotorasib clinical efficacy in KRAS-mutated non-small-cell lung cancer.
Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen, David S Hong, Herve Lena, Abraham Anderson

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.
Julien Dilly, Megan T Hoffman, Laleh Abbassi, Ziyue Li, Francesca Paradiso, Abraham Anderson

Cancer Discov· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary.
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S Falchook, Antoine Italiano, Abraham Anderson

Future Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib with panitumumab in chemotherapy-refractory KRAS-mutated colorectal cancer: a phase 1b trial.
Yasutoshi Kuboki, Marwan Fakih, John Strickler, Rona Yaeger, Toshiki Masuishi, Abraham Anderson

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100.
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, Gerald S Falchook, Antoine Italiano, Abraham Anderson

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL.
Deborah A Katz, Joan D Morris, Michael P Chu, Kevin A David, Catherine Thieblemont, Abraham A Anderson

Leuk Lymphoma· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib.
Joshua M Bauml, Bob T Li, Vamsidhar Velcheti, Ramaswamy Govindan, Alessandra Curioni-Fontecedro, Abraham Anderson

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia.
Andrew H Wei, Josep-Maria Ribera, Richard A Larson, David Ritchie, Armin Ghobadi, Abraham Anderson

Leukemia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib for Lung Cancers with p.G12C Mutation.
Ferdinandos Skoulidis, Bob T Li, Grace K Dy, Timothy J Price, Gerald S Falchook, Abraham Anderson

N Engl J Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma.
Josep Malvehy, Igor Samoylenko, Dirk Schadendorf, Ralf Gutzmer, Jean-Jacques Grob, Abraham Anderson

J Immunother Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Keizo Horibe, Joan D Morris, Catherine A Tuglus, Cedric Dos Santos, James Kalabus, Abraham Anderson

Int J Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia.
Hitoshi Kiyoi, Joan D Morris, Iekuni Oh, Yoshinobu Maeda, Hironobu Minami, Abraham Anderson

Cancer Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia.
Harry P Erba, Pamela S Becker, Paul J Shami, Michael R Grunwald, Donna L Flesher, Abraham A Anderson

Blood Adv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Antoni Ribas, Reinhard Dummer, Igor Puzanov, Ari VanderWalde, Robert H I Andtbacka, Abraham A Anderson

Cell· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Antoni Ribas, Reinhard Dummer, Igor Puzanov, Ari VanderWalde, Robert H I Andtbacka, Abraham A Anderson

Cell· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.
Hagop M Kantarjian, Michael W Schuster, Nitin Jain, Anjali Advani, Elias Jabbour, Abraham Anderson

Am J Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma.
Igor Puzanov, Mohammed M Milhem, David Minor, Omid Hamid, Ai Li, Abraham Anderson

J Clin Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
Timothy Iveson, Ross C Donehower, Irina Davidenko, Sergey Tjulandin, Andrzej Deptala, Abraham Anderson

Lancet Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain regions engaged by part- and whole-task performance in a video game: a model-based test of the decomposition hypothesis.
John R Anderson, Daniel Bothell, Jon M Fincham, Abraham R Anderson, Ben Poole

J Cogn Neurosci· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
Patrick Schöffski, Jorge A Garcia, Walter M Stadler, Thierry Gil, Eric Jonasch, Abraham Anderson

BJU Int· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
Patrick Y Wen, David Schiff, Timothy F Cloughesy, Jeffrey J Raizer, John Laterra, Abraham Anderson

Neuro Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib study of AMG 102 in combination with bevacizumab or motesanib in patients with advanced solid tumors.
Peter J Rosen, Christopher J Sweeney, Dorothy J Park, Darrin M Beaupre, Hongjie Deng, Abraham Anderson

Clin Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors.
Michael S Gordon, Christopher S Sweeney, David S Mendelson, S Gail Eckhardt, Abraham Anderson

Clin Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genomic analysis of the archaeal system Ignicoccus hospitalis-Nanoarchaeum equitans.
Mircea Podar, Iain Anderson, Kira S Makarova, James G Elkins, Natalia Ivanova, Abraham Anderson

Genome Biol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic islet expression profiling in diabetes-prone C57BLKS/J mice reveals transcriptional differences contributed by DBA loci, including Plagl1 and Nnt.
Abraham A Anderson, Joan Helmering, Todd Juan, Chi-Ming Li, Jocelyn McCormick

Pathogenetics· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis